Literature DB >> 19540390

Delayed improvement of right ventricular diastolic function and regression of right ventricular mass after percutaneous pulmonary valve implantation in patients with congenital heart disease.

Soha Romeih1, Lucia J Kroft, Regina Bokenkamp, Martin J Schalij, Heynric Grotenhuis, Mark G Hazekamp, Maarten Groenink, Albert de Roos, Nico A Blom.   

Abstract

BACKGROUND: Percutaneous pulmonary valve implantation (PPVI) has been introduced as therapy for right ventricular (RV) to pulmonary artery conduit dysfunction in patients with congenital heart disease. It has been shown that RV systolic function improved early after PPVI. The effects of PPVI on RV diastolic function and RV hypertrophy have not yet been studied.
PURPOSE: The objective of this study is to assess early and late changes in systolic and diastolic RV function and RV mass after PPVI.
MATERIALS AND METHODS: Fourteen patients underwent PPVI (7 male, median age 15 years). Cardiac magnetic resonance imaging was performed before and at 2 time points after PPVI (at 1 and 16 months). Right ventricular volume and systolic and diastolic function as well as RV mass were assessed.
RESULTS: At 1 and 16 months after PPVI, the RV mass decreased from 28.6 +/- 2.1 to 25.6 +/- 2.2 g/m(2) (P = .03) and to 22.3 +/- 2.1 g/m(2) (P = .002). E/A volume ratio increased from 1.91 +/- 0.4 to 2.6 +/- 0.4 (not significant [NS]) and to 3.3 +/- 0.4 (P = .01). E/A peak flow ratio increased from 1.34 +/- 0.14 to 1.48 +/- 0.16 (NS) and to 1.73 +/- 0.14 (P = .04). E-wave deceleration time increased from 142 +/- 25 to 160 +/- 27 milliseconds (NS) and to 211 +/- 26 milliseconds (P = .007). At 1 month, RV end-diastolic volume decreased from 124 +/- 8 to 113 +/- 8 mL (P = .01) and RV ejection fraction increased from 36% +/- 2% to 46% +/- 2% (P = .001) without further improvement at 16 months.
CONCLUSION: After PPVI, in contrast to rapid improvement of RV systolic function, the improvement of RV diastolic function is delayed. The reduction of RV mass appears to be the underlying mechanism for improvement of RV diastolic function. Long follow-up for patients with PPVI is recommended.

Entities:  

Mesh:

Year:  2009        PMID: 19540390     DOI: 10.1016/j.ahj.2009.04.023

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.

Authors:  Doff B McElhinney; William E Hellenbrand; Evan M Zahn; Thomas K Jones; John P Cheatham; James E Lock; Julie A Vincent
Journal:  Circulation       Date:  2010-07-19       Impact factor: 29.690

2.  Cardiac magnetic resonance before and after percutaneous pulmonary valve implantation.

Authors:  Francesco Secchi; Elda Chiara Resta; Luciane Piazza; Gianfranco Butera; Giovanni Di Leo; Mario Carminati; Francesco Sardanelli
Journal:  Radiol Med       Date:  2013-12-04       Impact factor: 3.469

3.  Changes in speckle tracking echocardiography measures of ventricular function after percutaneous implantation of the Edwards SAPIEN transcatheter heart valve in the pulmonary position.

Authors:  Shahryar M Chowdhury; Ziyad M Hijazi; John F Rhodes; Saibal Kar; Raj Makkar; Michael Mullen; Qi-Ling Cao; Lazar Mandinov; Jason Buckley; Nicholas P Pietris; Girish S Shirali
Journal:  Echocardiography       Date:  2014-07-22       Impact factor: 1.724

Review 4.  Heart failure in congenital heart disease: the role of genes and hemodynamics.

Authors:  Rachel D Vanderlaan; Christopher A Caldarone; Peter H Backx
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

Review 5.  Will catheter interventions replace surgery for valve abnormalities?

Authors:  Michael L O'Byrne; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2014-01       Impact factor: 2.161

6.  Cardiac imaging in adults with congenital heart disease: unknowns and issues related to diagnosis.

Authors:  Cylen Javidan-Nejad; Anderanik Tomasian; Elham Najafpour
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 7.  The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement.

Authors:  Doff B McElhinney; Jill T Hennesen
Journal:  Ann N Y Acad Sci       Date:  2013-07-08       Impact factor: 5.691

Review 8.  Recent advances in pediatric interventional cardiology.

Authors:  Seong-Ho Kim
Journal:  Korean J Pediatr       Date:  2017-08-14

9.  Favorable Atrial Remodeling After Percutaneous Pulmonary Valve Implantation and Its Association With Changes in Exercise Capacity and Right Ventricular Function.

Authors:  Heiner Latus; Danik Born; Nerejda Shehu; Heiko Stern; Alfred Hager; Stainimir Georgiev; Daniel Tanase; Christian Meierhofer; Peter Ewert; Andreas Eicken; Oktay Tutarel
Journal:  J Am Heart Assoc       Date:  2021-10-06       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.